Jennifer Connelly

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

Benjamin M. Ellingson, Mark G. Malkin, Scott D. Rand et al. · Journal of Magnetic Resonance Imaging · 2010 · 274 citations · Full text

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

Kathleen M. Schmainda, Melissa Prah, Jennifer Connelly et al. · Neuro-Oncology · 2014 · 119 citations · Full text

Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma

Peter S. LaViolette, Nikolai J. Mickevicius, Elizabeth J. Cochran et al. · Neuro-Oncology · 2014 · 82 citations · Full text

Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy

Sean D. McGarry, Sarah Hurrell, Amy Kaczmarowski et al. · Tomography · 2016 · 82 citations · Full text